A detailed history of Global Wealth Strategies & Associates transactions in Novo Nordisk A S stock. As of the latest transaction made, Global Wealth Strategies & Associates holds 120 shares of NVO stock, worth $15,746. This represents 0.01% of its overall portfolio holdings.

Number of Shares
120
Previous 120 -0.0%
Holding current value
$15,746
Previous $15.4 Million 11.17%
% of portfolio
0.01%
Previous 0.01%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Oct 20, 2023

BUY
$90.94 - $199.54 $5,456 - $11,972
60 Added 100.0%
120 $10.9 Million
Q4 2022

Jan 17, 2023

BUY
$102.55 - $135.33 $6,153 - $8,119
60 New
60 $8.12 Million

Others Institutions Holding NVO

About NOVO NORDISK A S


  • Ticker NVO
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 2,257,289,984
  • Market Cap $296B
  • Description
  • Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...
More about NVO
Track This Portfolio

Track Global Wealth Strategies & Associates Portfolio

Follow Global Wealth Strategies & Associates and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Global Wealth Strategies & Associates, based on Form 13F filings with the SEC.

News

Stay updated on Global Wealth Strategies & Associates with notifications on news.